Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchison China Regulatory News (HCM)

Share Price Information for Hutchison China (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 514.00
Bid: 502.00
Ask: 528.00
Change: 0.00 (0.00%)
Spread: 26.00 (5.18%)
Open: 514.00
High: 527.74
Low: 502.26
Yest. Close: 514.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
Date   Source Headline
13th Mar 20177:00 amRNSFinal Results
10th Mar 20178:11 amRNSSulfatinib Phase Ib/II Results Presented at ENETS
10th Mar 20177:18 amRNSSulfatinib Phase Ib/II Results Presented at ENETS
7th Mar 201711:49 amEQSEdison issues update on Hutchison China Meditech (HCM)
3rd Mar 20177:00 amRNSPositive Fruquintinib Pivotal Phase III Results
28th Feb 201710:20 amRNSChange of Directors
20th Feb 20177:00 amRNSStart of Phase II Savolitinib PSC trial in China
14th Feb 20177:07 amRNSInitiates Phase I of Novel FGFR Inhibitor HMPL-453
14th Feb 20177:00 amRNSSavolitinib PRCC Results Presentation at ASCO GU
6th Feb 20177:00 amRNSChi-Med to Announce 2016 Final Results
1st Feb 20177:00 amRNSChange of Directors
16th Jan 201710:48 amRNSChange of Directors
16th Jan 201710:11 amRNSChange of Directors
16th Jan 20177:30 amRNSFruquintinib Phase I/II Clinical Data at ASCO GI
16th Jan 20177:29 amRNSSulfatinib Phase II Study in 2nd Line BTC in China
16th Jan 20177:16 amRNSFruquintinib Combination Study in 1st-Line NSCLC
10th Jan 20177:00 amRNSChi-Med Initiates HMPL-523 Clinical Trials
30th Dec 20169:11 amRNSTotal Voting Rights
29th Dec 20167:40 amRNSBlocklisting Six Monthly Return
20th Dec 20167:18 amRNSDirector's Share Dealing
14th Dec 20167:14 amRNSDirector's Share Dealing
6th Dec 20167:00 amRNSHMPL-523 Pre-clinical Data Presented at ASH
30th Nov 20167:51 amRNSExercise of Share Options
30th Nov 20167:48 amRNSTotal Voting Rights
23rd Nov 20167:34 amRNSDirector's Share Dealing
23rd Nov 20167:30 amRNSChi-Med to Present Data at the 17th WCLC
23rd Nov 20167:08 amRNSChi-Med to Present Data at the at the 17th WCLC
14th Nov 20169:06 amRNSChi-Med Presents Ph I Clinical Data for HMPL-523
1st Nov 20162:57 pmRNSDirector's Share Dealing
31st Oct 20167:00 amRNSJoint Venture - US$59.5m Land Compensation Payment
12th Oct 20167:00 amRNSDirector's Share Dealing
9th Aug 20168:07 amRNSDirector's Share Dealing
2nd Aug 20168:18 amRNSChange of Non-executive Directors
2nd Aug 20167:00 amRNSChi-Med 2016 Interim Results
1st Aug 20167:21 amRNSChi-Med and AstraZeneca to Accelerate Savolitinib
5th Jul 20167:00 amRNSChi-Med to Announce 2016 HY Financial Results
29th Jun 20167:00 amRNSBlocklisting Six Monthly Return
20th Jun 20167:00 amRNSSavolitinib Global Phase II Trial Initiated
15th Jun 20168:09 amRNSAdditional Listing
31st May 20167:00 amRNSTotal Voting Rights
13th May 20167:00 amRNSEnrollment completion of Phase III fruquintinib
29th Apr 20167:00 amRNSTotal Voting Rights
27th Apr 20161:12 pmRNSResults of Annual General Meeting
13th Apr 20164:23 pmRNSExercise of Overallotment Option
31st Mar 20167:00 amRNSTotal Voting Rights
29th Mar 20168:00 amRNSDirector/PDMR Shareholding
23rd Mar 201610:34 amRNSHolding(s) in Company
22nd Mar 20162:00 pmRNSClosing of U.S. Public Offering of ADSs
21st Mar 20168:54 amRNSDirector/PDMR Shareholding
21st Mar 20167:00 amRNSSulfatinib Phase III registration study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.